EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer

Clinical Genitourinary Cancer

Volumn 12, Issue 4, 2014, Pages 278-286

  May, Matthias ^a,b,c   Burger, Maximilian ^d   Brookman May, Sabine ^e   Stief, Christian G ^e   Fritsche, Hans Martin ^d   Roigas, Jan ^b   Zacharias, Mario ^c   Bader, Markus ^e   Mandel, Philipp ^e   Gilfrich, Christian ^a   Seitz, Michael ^e   Tilki, Derya ^e  

^a Urologische Klinik   (Germany)

^b VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

^c Vivantes Klinikum AVK Berlin   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

EORTC risk tables; Muscle invasion; Prognosis; Risk stratification; Urothelial carcinoma of the bladder

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SPECIFIC MORTALITY; CANCER STAGING; CAUSE OF DEATH; COMPARATIVE STUDY; CYSTECTOMY; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER PROGRESSION SCORE; FEMALE; GENERAL CONDITION DETERIORATION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE BLADDER CANCER; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIMARY TUMOR; SECOND CANCER; TRANSURETHRAL RESECTION; TRANSURETHRAL RESECTION OF BLADDER CANCER; TUMOR DIAGNOSIS; TUMOR GROWTH; TUMOR INVASION; CANCER GRADING; DISEASE COURSE; FOLLOW UP; MORTALITY; MUSCLE NEOPLASMS; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

AGED; CYSTECTOMY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MUSCLE NEOPLASMS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 84904736993     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2013.11.014     Document Type: Article

References (24)

1. A. Stenzl, H. Sherif, and M. Kuczyk Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results Int Braz J Urol 36 2010 537 547
2. A. Stenzl, N.C. Cowan, and M. De Santis et al. The updated EAU guidelines on muscle-invasive and metastatic bladder cancer Eur Urol 55 2009 815 825
3. H.M. Bruins, G.J. Huang, and J. Cai et al. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy J Urol 182 2009 2182 2187
4. A. Karl, P.R. Carroll, and J.E. Gschwend et al. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer Eur Urol 55 2009 826 835
5. R.R. de Vries, J.A. Nieuwenhuijzen, and A. Vincent et al. Survival after cystectomy for invasive bladder cancer Eur J Surg Oncol 36 2010 292 297
6. C.T. Lee, R.L. Dunn, and C. Ingold et al. Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion Urology 69 2007 1068 1072
7. M. May, S. Fuhrer, and K.P. Braun et al. Results from three municipal hospitals regarding radical cystectomy on elderly patients Int Braz J Urol 33 2007 764 773
8. M. May, C. Helke, and T. Nitzke et al. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation Urol Int 72 2004 103 111
9. R. Yiou, J.J. Patard, and H. Benhard et al. Outcome of radical cystectomy for bladder cancer according to the disease type at presentation BJU Int 89 2002 374 378
10. A. Aziz, M. Gierth, and H.M. Fritsche et al. Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy Urol Int 91 2013 97 102
11. A.M. Leliveld, B.H. Doornweerd, and E. Bastiaannet et al. Treatment and outcome in muscle invasive bladder cancer: a population-based survey World J Urol 28 2010 439 444
12. R.J. Sylvester, A.P. van der Meijden, and W. Oosterlinck et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 466 475
13. N.M. Fahmy, S. Mahmud, and A.G. Aprikian Delay in the surgical treatment of bladder cancer and survival: systematic review of the literature Eur Urol 50 2006 1176 1182
14. J.L. Gore, J. Lai, and C.M. Setodji et al. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis Cancer 115 2009 988 996
15. C.T. Lee, R. Madii, and S. Daignault et al. Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival J Urol 175 2006 1262 1267
16. M. May, T. Nitzke, and C. Helke et al. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder Scand J Urol Nephrol 38 2004 231 235
17. M. Babjuk, W. Oosterlinck, and R. Sylvester et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 Update Eur Urol 59 2011 997 1008
18. S.F. Shariat, D.C. Chade, and P.I. Karakiewicz et al. Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer J Urol 183 2010 68 75
19. V. Soukup, M. Babjuk, and J. Duskova et al. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma? Urol Int 80 2008 413 418
20. A.F. Kotb, E. Kovac, and W. Kassouf et al. Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes? World J Urol 30 2012 761 767
21. B.P. Schrier, M.P. Hollander, and B.W. van Rhijn et al. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy Eur Urol 45 2004 292 296
22. G. Dalbagni, K. Vora, and M. Kaag et al. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer Eur Urol 56 2009 903 910
23. G.S. Kulkarni, D.R. Urbach, and P.C. Austin et al. Longer wait times increase overall mortality in patients with bladder cancer J Urol 182 2009 1318 1324
24. M.E. Nielsen, G.S. Palapattu, and P.I. Karakiewicz et al. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome BJU Int 100 2007 1015 1020